Smart Immune

About:

Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform.

Website: https://www.smart-immune.com

Top Investors: European Innovation Council, Bill & Melinda Gates Foundation, Sebastian Lombardo, La French Tech

Description:

Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells) curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.

Total Funding Amount:

$27.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2017-07-17

Contact Email:

karine.rossignol(AT)smart-immune.com

Founders:

Isabelle André, Karine Rossignol, Marina Cavazzana

Number of Employees:

11-50

Last Funding Date:

2023-04-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai